Genomic alterations in circulating tumor DNA (ctDNA) and response to telisotuzumab adizutecan (ABBV-400) treatment in patients (pts) with colorectal cancer (CRC).

Authors :: Cecchini, Michael
Sharma, Manish R
Kuboki, Yasutoshi
Perets, Ruth
Cohen, Jonathan
Raimbourg, Judith
Nakajima, Takako Eguchi
Cruz-Correa, Marcia
Ghiringhelli, François
Raghav, Kanwal Pratap Singh
Vasilopoulos, Athanasios
Luo, Xizhi
Neagu Aristide, Martha Raluca
Morrison Thiele, Gladys
Hunter, Zoe
Burns, Michael Charles
Roberts-Rapp, Lisa
Strickler, John H
Source :: Journal of Clinical Oncology; 2025 Supplement 4, Vol. 43, p258-258, 307p
Publication Year :: 2025

Full Text Access

Tools